Attached files
Exhibit
31.1
CERTIFICATION
I, Robert McDermott, certify that:
1. I have reviewed this quarterly report on Form 10-Q of iMedicor,
Inc. for the period ended March 31, 2015;
2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in
all material respects the financial condition, results of
operations and cash flows of the issuer as of, and for, the periods
presented in this report;
4. As the issuer's certifying officer I am responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
issuer and have:
a. designed
such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this year-end report is
being prepared;
b.
evaluated the effectiveness of the registrantís disclosure
controls and procedures as of the end of the period (the
“Evaluation Date”); and
c.
presented in this year-end report our conclusions about the
effectiveness of the disclosure controls and procedures based on
our evaluation as of the Evaluation Date;
5. The issuer's other certifying officer and I have disclosed,
based on our most recent evaluation, of internal control over
financial reporting, to the issuer's auditors and the audit
committee of the issuer's board of directors (or persons performing
the equivalent functions):
a.
all significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are
reasonably likely to adversely affect the issuer's ability to
record, process, summarize and report financial information;
and
b.
any fraud, whether or not material, that involves management or
other employees who have a significant role in the issuer's
internal control over financial reporting.
6. As the registrantís certifying officer I have
indicated in this year-end report whether there were significant
changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of
our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material
weaknesses.
/s/ Robert
McDermott
Robert McDermott
Chief Executive Officer
(Principal Executive Officer)
Date: September 29, 2016